| Rationale for randomised trials of prostate cancer screening. The International Prostate Screening Trial Evaluation Group. |
10448269
|
|
Eur. J. Cancer |
1999 |
|
| Participation in breast cancer risk counseling among women with a family history. |
10428194
|
Bowen D, McTiernan A, Burke W, Powers D, Pruski J, Durfy S, Gralow J, Malone K |
Cancer Epidemiol Biomarkers Prev |
1999 |
PLCO |
| Recruiting black men to a clinical trial to evaluate prostate cancer screening--Detroit, Michigan, 1998. |
9733417
|
Centers for Disease Control and Prevention (CDC) |
MMWR Morb. Mortal. Wkly. Rep. |
1998 |
PLCO |
| Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan. |
9709271
|
Shapiro S |
J. Natl. Cancer Inst. Monographs |
1997 |
HIPB |
| Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group. |
8849769
|
Auvinen A, Rietbergen JB, Denis LJ, Schröder FH, Prorok PC |
J Med Screen |
1996 |
|
| Screening and prevention trials step up minority recruitment. |
8797765
|
Reynolds T |
J. Natl. Cancer Inst. |
1996 |
PLCO |
| The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial of the National Cancer Institute. |
|
Gohagan JK, Prorok PC, Kramer BS, Hayes RB, Cornett JE |
Cancer |
1995 |
PLCO |
| Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. |
7523735
|
Gohagan JK, Prorok PC, Kramer BS, Cornett JE |
J. Urol. |
1994 |
PLCO |
| "Screening for prostate cancer". |
7528519
|
Gohagan JK, Kramer BS, Greenwald P |
Am J Prev Med |
1994 |
|
| NIH Consensus 1994: screening. |
7835804
|
Kramer BS, Gohagan J, Prorok PC |
Gynecol. Oncol. |
1994 |
PLCO |
| The National Cancer Institute multi-screening trial. |
|
Prorok PC, Gohagan J, Kramer B |
Canadian J Urol |
1994 |
PLCO |
| The National Cancer Institute Multi-Screening Trial. |
8853500
|
Prorok P |
Can J Oncol |
1994 |
NLST |
| A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. |
8420681
|
Kramer BS, Gohagan J, Prorok PC, Smart C |
Cancer |
1993 |
PLCO |
| Prostate cancer screening: what we know and what we need to know. |
7692780
|
Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK |
Ann. Intern. Med. |
1993 |
PLCO |
| Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. |
8474513
|
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F |
N Engl J Med |
1993 |
MINN |
| Screening for Lung Cancer: Recent Experience in the United States |
|
Fontana RS, In Hansen HH |
Lung Cancer: Basic and Clinical Aspects. |
1986 |
MAYO |
| Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. |
6091506
|
Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N |
Am. Rev. Respir. Dis. |
1984 |
MEM |
| Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. |
6734291
|
Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N |
Chest |
1984 |
MEM |
| Evidence on screening for breast cancer from a randomized trial. |
326378
|
Shapiro S |
Cancer |
1977 |
HIPB |
| Impact of efforts to increase participation in repetitive screenings for early breast cancer detection. |
5011163
|
Fink R, Shapiro S, Roester R |
Am J Public Health |
1972 |
HIPB |
